As it continues to ramp up sales of its attention-deficit/hyperactivity disorder (ADHD) drug Qelbree, Supernus Pharmaceuticals is getting Busy to raise awareness of ...

May 20, 2025 (GLOBE NEWSWIRE) -- Actress, author, podcaster, and mom, Busy Philipps, is stepping into an important new role as 'Ms. Represented' in partnership with Supernus Pharmaceuticals for a new ...

Busy Philipps partners with Supernus Pharmaceuticals to launch a campaign addressing ADHD in women, sharing her personal journey with Qelbree. Actress Busy Philipps has partnered with Supernus ...

Short interest in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) decreased during the last reporting period, falling from 4.14M to 3.97M. This put 10.76% of the company's publicly available shares short.

President and CEO of Supernus. “In addition, we are pleased to be bringing ONAPGO to market, another growth driver for our business. ONAPGO represents a novel approach for adults with Parkinson ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Clearly, options traders are pricing in a big move for Supernus Pharmaceuticals shares, but what is the fundamental picture for the company? Currently, Supernus Pharmaceuticals is a Zacks Rank #3 ...